Literature DB >> 9767634

Structure-based design of beta-lactamase inhibitors. 2. Synthesis and evaluation of bridged sulfactams and oxamazins.

C Hubschwerlen1, P Angehrn, K Gubernator, M G Page, J L Specklin.   

Abstract

A series of bridged monocyclic beta-lactams activated by various groups on the beta-lactam nitrogen (X = OCH2CO2H, OSO3H) has been synthesized and evaluated. Among them, the bridged sulfactams (X = OSO3H) were found to be effective beta-lactamase inhibitors. They inhibit both class A and class C beta-lactamases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9767634     DOI: 10.1021/jm9800245

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  4 in total

1.  The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Synthesis of complex allylic esters via C-H oxidation vs C-C bond formation.

Authors:  Nicolaas A Vermeulen; Jared H Delcamp; M Christina White
Journal:  J Am Chem Soc       Date:  2010-08-18       Impact factor: 15.419

3.  A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems.

Authors:  Krisztina M Papp-Wallace; Susana Mallo; Christopher R Bethel; Magdalena A Taracila; Andrea M Hujer; Ana Fernández; Julian A Gatta; Kerri M Smith; Yan Xu; Malcolm G P Page; Eric Desarbre; Germán Bou; Robert A Bonomo
Journal:  J Antimicrob Chemother       Date:  2013-11-13       Impact factor: 5.790

Review 4.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.